Your session is about to expire
← Back to Search
Antimicrobial Therapy + SBRT for Lung Cancer
Study Summary
This trial is testing whether adding vancomycin to SBRT increases the effectiveness of SBRT by measuring the Th1 immune response.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for targeted radiation therapy for my lung cancer.I understand the details of the trial and can agree to participate.I have not taken antibiotics, antifungals, antivirals, or antiparasitics in the last 4 weeks.I haven't started chemotherapy in the last 4 weeks or during my radiotherapy.I have a documented history of HIV, hepatitis B, or hepatitis C.I do not have ongoing severe stomach or bowel problems.I have not had major GI surgery, except for gallbladder or appendix removal, in the last 5 years.I am currently taking probiotics.I currently have a fever over 100°F.I haven't taken steroids, methotrexate, or immunosuppressants in the last 4 weeks.I am currently taking medication for diarrhea.I have chronic constipation, with bowel movements less frequent than every other day.I am 18 years old or older.
- Group 1: Arm 1 - Experimental
- Group 2: Arm 2 - Control Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there other investigations that have incorporated Vancomycin in the past?
"At present, 55 Vancomycin clinical trials are ongoing; 6 of which have reached Phase 3. Although Jupiter, Florida is the epicentre for research on this antibiotic, a total of 315 sites across the nation are running experiments with it."
Are there any remaining openings for individuals to take part in this trial?
"Affirmative. Information hosted on clinicaltrials.gov attests that this trial, which was originally posted on April 24th 2018, is actively seeking participants. Solely one medical centre needs to recruit 40 individuals for the study."
What medical conditions has Vancomycin been instrumental in alleviating?
"Vancomycin is a suitable therapy for staphylococcal infections, colonization by the bacteria Staphyloccocus, and enterocolitis caused by S. Aureus."
How many participants are currently enrolled in this clinical examination?
"Affirmative, the clinicaltrials.gov repository indicates that this medical trial is actively recruiting participants. The posting was originally published on April 24th 2018 and has been updated most recently on November 1st 2022. Forty patients need to be recruited from a single location for this study."
Share this study with friends
Copy Link
Messenger